Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
135.44
-2.87 (-2.08%)
At close: Jul 22, 2026, 4:00 PM EDT
135.44
0.00 (0.00%)
Pre-market: Jul 23, 2026, 7:25 AM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $8.71 billion as of July 23, 2026. Its market cap has increased by 154.49% in one year.
Market Cap
8.71B
Enterprise Value
8.10B
1-Year Change
154.49%
Ranking
Category
Stock Price
$135.44
ChartMarket Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $8.71B, an increase of 4,978.91%. That is a compound annual growth rate of 48.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 8.71B | 59.53% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 10.22B |
| Apogee Therapeutics | 10.05B |
| Corcept Therapeutics | 9.81B |
| Kymera Therapeutics | 9.43B |
| Halozyme Therapeutics | 9.23B |
| Ionis Pharmaceuticals | 8.98B |
| Spyre Therapeutics | 8.85B |
| Crinetics Pharmaceuticals | 8.84B |